newsfilter
← Latest News
GlobeNewswire·

Imago BioSciences to Participate in Guggenheim Healthcare Talks 2022 Oncology Conference

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announc